As of 2026-03-17, the Relative Valuation of Black Diamond Therapeutics Inc (BDTX) is 8.62 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.19 USD, the upside of Black Diamond Therapeutics Inc based on Relative Valuation is 293.5%.
The range of the Relative Valuation is 7.99 - 9.65 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.2x - 25.6x | 23.4x |
| Forward P/E multiples | 21.6x - 23.0x | 22.3x |
| Fair Price | 7.99 - 9.65 | 8.62 |
| Upside | 265.0% - 340.8% | 293.5% |
| Date | P/E |
| 2026-03-13 | 5.62 |
| 2026-03-12 | 5.65 |
| 2026-03-11 | 5.97 |
| 2026-03-10 | 6.02 |
| 2026-03-09 | 5.78 |
| 2026-03-06 | 5.70 |
| 2026-03-05 | 5.44 |
| 2026-03-04 | 6.52 |
| 2026-03-03 | 6.10 |
| 2026-03-02 | 6.44 |
| 2026-02-27 | 6.55 |
| 2026-02-26 | 6.63 |
| 2026-02-25 | 6.87 |
| 2026-02-24 | 6.76 |
| 2026-02-23 | 6.39 |
| 2026-02-20 | 6.18 |
| 2026-02-19 | 6.10 |
| 2026-02-18 | 5.99 |
| 2026-02-17 | 5.91 |
| 2026-02-13 | 5.89 |
| 2026-02-12 | 5.81 |
| 2026-02-11 | 5.89 |
| 2026-02-10 | 6.05 |
| 2026-02-09 | 5.94 |
| 2026-02-06 | 5.98 |
| 2026-02-05 | 5.73 |
| 2026-02-04 | 6.34 |
| 2026-02-03 | 6.68 |
| 2026-02-02 | 6.74 |
| 2026-01-30 | 6.60 |
| 2026-01-29 | 6.97 |
| 2026-01-28 | 6.82 |
| 2026-01-27 | 6.87 |
| 2026-01-26 | 6.79 |
| 2026-01-23 | 6.92 |
| 2026-01-22 | 7.03 |
| 2026-01-21 | 6.82 |
| 2026-01-20 | 6.36 |
| 2026-01-16 | 6.79 |
| 2026-01-15 | 7.08 |
| 2026-01-14 | 7.40 |
| 2026-01-13 | 7.29 |
| 2026-01-12 | 7.00 |
| 2026-01-09 | 7.45 |
| 2026-01-08 | 7.37 |
| 2026-01-07 | 7.19 |
| 2026-01-06 | 6.89 |
| 2026-01-05 | 6.82 |
| 2026-01-02 | 6.60 |
| 2025-12-31 | 6.44 |